BRIEF-Medicus Pharma Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The Skin

Reuters

Nov 17

BRIEF-<a href="https://laohu8.com/S/MDCX">Medicus Pharma</a> Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The Skin

Nov 17 (Reuters) - Medicus Pharma Ltd MDCX.O:

MEDICUS PHARMA LTD. ANNOUNCES FILING OF FDA COMMISSIONER’S NATIONAL PRIORITY VOUCHER APPLICATION (CNPV) FOR SKNJCT-003 TO NON-INVASIVELY TREAT BASAL CELL CARCINOMA $(BCC)$ OF THE SKIN

Source text: ID:nGNX8DChYb

Further company coverage: MDCX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2584623331"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2584623331\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2584623331?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-17 20:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584623331","market":"us","top_or_hot":-1,"title":"BRIEF-Medicus Pharma Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The Skin","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/MDCX\">Medicus Pharma</a> Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The Skin</title></head><body><p><span>Nov 17 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/MDPLF\">Medicus Pharma</a> Ltd <span>MDCX.O</span>:</p><ul><li><p><a href=\"https://laohu8.com/S/MDPLD\">MEDICUS PHARMA LTD.</a> ANNOUNCES FILING OF FDA COMMISSIONER’S NATIONAL PRIORITY VOUCHER APPLICATION (CNPV) FOR SKNJCT-003 TO NON-INVASIVELY TREAT BASAL CELL CARCINOMA <a href=\"https://laohu8.com/S/BCC\">$(BCC)$</a> OF THE SKIN</p></li></ul><p>Source text: <span>ID:nGNX8DChYb</span></p><p>Further company coverage: <span>MDCX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Medicus Pharma Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The Skin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Medicus Pharma Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The Skin\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-17 20:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/MDCX\">Medicus Pharma</a> Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The Skin</title></head><body><p><span>Nov 17 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/MDPLF\">Medicus Pharma</a> Ltd <span>MDCX.O</span>:</p><ul><li><p><a href=\"https://laohu8.com/S/MDPLD\">MEDICUS PHARMA LTD.</a> ANNOUNCES FILING OF FDA COMMISSIONER’S NATIONAL PRIORITY VOUCHER APPLICATION (CNPV) FOR SKNJCT-003 TO NON-INVASIVELY TREAT BASAL CELL CARCINOMA <a href=\"https://laohu8.com/S/BCC\">$(BCC)$</a> OF THE SKIN</p></li></ul><p>Source text: <span>ID:nGNX8DChYb</span></p><p>Further company coverage: <span>MDCX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDCX","symbol_name":"Medicus Pharma Ltd.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nFWN3WT16W:1","article_id":"2584623331","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584623331","pubTimestamp":1763382905,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Medicus Pharma Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The SkinNov 17 (Reuters) -","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDCX":"Medicus Pharma Ltd.","BK4139":"生物科技"},"translate_title":"简介-Medicus Pharma宣布提交FDA专员关于Sknjct-003的国家优先凭证申请(Cnpv)，用于非侵入性治疗皮肤基底细胞癌(Bcc)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDCX":0.9},"content_text":"BRIEF-Medicus Pharma Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The SkinNov 17 (Reuters) - Medicus Pharma Ltd MDCX.O:MEDICUS PHARMA LTD. ANNOUNCES FILING OF FDA COMMISSIONER’S NATIONAL PRIORITY VOUCHER APPLICATION (CNPV) FOR SKNJCT-003 TO NON-INVASIVELY TREAT BASAL CELL CARCINOMA $(BCC)$ OF THE SKINSource text: ID:nGNX8DChYbFurther company coverage: MDCX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}